Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Status:
Terminated
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this international multi-center double-blind randomized placebo-controlled
trial is to determine the effect of nebulized heparin, compared to placebo, on the number of
ventilator-free days at day 28, in burn patients with confirmed inhalation trauma requiring
mechanical ventilation.
Phase:
Phase 3
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)